SG11201807574XA - Beta-caseins and cognitive function - Google Patents
Beta-caseins and cognitive functionInfo
- Publication number
- SG11201807574XA SG11201807574XA SG11201807574XA SG11201807574XA SG11201807574XA SG 11201807574X A SG11201807574X A SG 11201807574XA SG 11201807574X A SG11201807574X A SG 11201807574XA SG 11201807574X A SG11201807574X A SG 11201807574XA SG 11201807574X A SG11201807574X A SG 11201807574XA
- Authority
- SG
- Singapore
- Prior art keywords
- beta
- international
- casein
- pct
- milk
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title abstract 6
- 108010076119 Caseins Proteins 0.000 title abstract 6
- 235000021247 β-casein Nutrition 0.000 title abstract 5
- 230000003920 cognitive function Effects 0.000 title abstract 3
- 235000013336 milk Nutrition 0.000 abstract 3
- 239000008267 milk Substances 0.000 abstract 3
- 210000004080 milk Anatomy 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000029087 digestion Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 102220240796 rs553605556 Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
- A23V2250/54246—Casein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315441P | 2016-03-30 | 2016-03-30 | |
| PCT/NZ2017/050035 WO2017171563A1 (en) | 2016-03-30 | 2017-03-29 | Beta-caseins and cognitive function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201807574XA true SG11201807574XA (en) | 2018-10-30 |
Family
ID=59964978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201807574XA SG11201807574XA (en) | 2016-03-30 | 2017-03-29 | Beta-caseins and cognitive function |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11504412B2 (es) |
| EP (1) | EP3436038B1 (es) |
| JP (1) | JP7394527B2 (es) |
| KR (1) | KR102471621B1 (es) |
| CN (1) | CN109069540B (es) |
| AU (1) | AU2017240635B2 (es) |
| BR (1) | BR112018068817A2 (es) |
| CA (1) | CA3017727C (es) |
| CL (1) | CL2018002688A1 (es) |
| ES (1) | ES2886647T3 (es) |
| IL (1) | IL261704B (es) |
| MX (1) | MX2018011817A (es) |
| MY (1) | MY193655A (es) |
| NZ (1) | NZ746167A (es) |
| PH (1) | PH12018550149A1 (es) |
| RU (1) | RU2766194C2 (es) |
| SG (1) | SG11201807574XA (es) |
| TW (1) | TWI831732B (es) |
| WO (1) | WO2017171563A1 (es) |
| ZA (1) | ZA201806247B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7394527B2 (ja) | 2016-03-30 | 2023-12-08 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼイン類および認知機能 |
| NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
| CN114586983A (zh) * | 2022-03-07 | 2022-06-07 | 黑龙江飞鹤乳业有限公司 | 一种促神经发育营养组合物及其制备和应用 |
| CN114716531B (zh) * | 2022-05-17 | 2023-11-03 | 中国农业科学院农业质量标准与检测技术研究所 | 一种酪蛋白多肽、多肽抗原、抗体、试纸条及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU691362B2 (en) * | 1994-11-04 | 1998-05-14 | New Zealand Dairy Board | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
| CA2217820C (en) | 1995-05-16 | 2011-03-01 | Corran Norman Stuart Mclachlan | Milk and milk products for preventing or treating heart disease |
| RU2161500C1 (ru) * | 1999-07-06 | 2001-01-10 | Институт молекулярной генетики РАН | Гептапептид с адаптогенной и анксиолитической активностью |
| AU9037401A (en) * | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
| US20100166859A1 (en) * | 2006-01-16 | 2010-07-01 | Luppo Edens | Novel nutraceutical compositions and use thereof |
| EP2422629A1 (en) | 2010-08-23 | 2012-02-29 | Abbott Laboratories | Methods for enhancing cognition and/or memory using maltodextrins |
| AU2014271423B2 (en) | 2013-05-31 | 2018-12-20 | The A2 Milk Company Limited | Beta-casein A2 and prevention of inflammation of the bowel |
| EP3542805A1 (en) * | 2013-07-12 | 2019-09-25 | The A2 Milk Company Limited | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
| KR102626825B1 (ko) | 2013-08-23 | 2024-01-17 | 디 에이2 밀크 컴퍼니 리미티드 | 베타-카세인 ａ２ 및 혈중 글루코스 수준 |
| WO2015187795A1 (en) * | 2014-06-03 | 2015-12-10 | Abbott Laboratories | Nutritional compositions comprising a lipophilic active ingredient |
| JP6005202B2 (ja) * | 2015-03-19 | 2016-10-12 | アサヒグループホールディングス株式会社 | 脳機能改善用ペプチドの酵素的製造方法 |
| CN107708711A (zh) | 2015-05-22 | 2018-02-16 | 艾尔牛奶有限公司 | β‑酪蛋白A2和抗氧化能力 |
| CN105053217A (zh) * | 2015-09-14 | 2015-11-18 | 海普诺凯营养品有限公司 | 一种婴幼儿配方羊奶粉及其制作方法 |
| CN108472335A (zh) | 2015-12-22 | 2018-08-31 | 艾尔牛奶有限公司 | 包含人乳肽的婴儿配方产品 |
| JP7394527B2 (ja) | 2016-03-30 | 2023-12-08 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼイン類および認知機能 |
-
2017
- 2017-03-29 JP JP2018551398A patent/JP7394527B2/ja active Active
- 2017-03-29 BR BR112018068817A patent/BR112018068817A2/pt unknown
- 2017-03-29 CA CA3017727A patent/CA3017727C/en active Active
- 2017-03-29 KR KR1020187029896A patent/KR102471621B1/ko active IP Right Grant
- 2017-03-29 CN CN201780017821.8A patent/CN109069540B/zh active Active
- 2017-03-29 US US16/084,853 patent/US11504412B2/en active Active
- 2017-03-29 MY MYPI2018703463A patent/MY193655A/en unknown
- 2017-03-29 RU RU2018132691A patent/RU2766194C2/ru active
- 2017-03-29 ES ES17775963T patent/ES2886647T3/es active Active
- 2017-03-29 WO PCT/NZ2017/050035 patent/WO2017171563A1/en active Application Filing
- 2017-03-29 AU AU2017240635A patent/AU2017240635B2/en active Active
- 2017-03-29 SG SG11201807574XA patent/SG11201807574XA/en unknown
- 2017-03-29 MX MX2018011817A patent/MX2018011817A/es unknown
- 2017-03-29 NZ NZ746167A patent/NZ746167A/en unknown
- 2017-03-29 EP EP17775963.6A patent/EP3436038B1/en not_active Revoked
- 2017-03-30 TW TW106110702A patent/TWI831732B/zh active
-
2018
- 2018-09-05 PH PH12018550149A patent/PH12018550149A1/en unknown
- 2018-09-12 IL IL261704A patent/IL261704B/en unknown
- 2018-09-17 ZA ZA2018/06247A patent/ZA201806247B/en unknown
- 2018-09-21 CL CL2018002688A patent/CL2018002688A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12018550149A1 (en) | 2019-03-25 |
| JP7394527B2 (ja) | 2023-12-08 |
| ES2886647T3 (es) | 2021-12-20 |
| CN109069540A (zh) | 2018-12-21 |
| JP2019509755A (ja) | 2019-04-11 |
| MX2018011817A (es) | 2019-01-24 |
| EP3436038B1 (en) | 2021-06-23 |
| CL2018002688A1 (es) | 2019-01-18 |
| AU2017240635B2 (en) | 2023-01-19 |
| AU2017240635A1 (en) | 2018-10-04 |
| RU2766194C2 (ru) | 2022-02-09 |
| US20190083567A1 (en) | 2019-03-21 |
| CA3017727A1 (en) | 2017-10-05 |
| CA3017727C (en) | 2024-03-12 |
| TWI831732B (zh) | 2024-02-11 |
| NZ746167A (en) | 2023-04-28 |
| RU2018132691A3 (es) | 2020-06-25 |
| BR112018068817A2 (pt) | 2019-01-22 |
| CN109069540B (zh) | 2023-03-28 |
| EP3436038A4 (en) | 2019-11-20 |
| KR102471621B1 (ko) | 2022-11-25 |
| KR20180129829A (ko) | 2018-12-05 |
| IL261704B (en) | 2022-04-01 |
| MY193655A (en) | 2022-10-23 |
| EP3436038A1 (en) | 2019-02-06 |
| IL261704A (en) | 2018-10-31 |
| RU2018132691A (ru) | 2020-04-30 |
| WO2017171563A1 (en) | 2017-10-05 |
| US11504412B2 (en) | 2022-11-22 |
| TW201737936A (zh) | 2017-11-01 |
| ZA201806247B (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201810602YA (en) | Method of treating liver fibrosis | |
| SG11201805470VA (en) | Code and container of system for preparing a beverage or foodstuff | |
| SG11201805828YA (en) | Method of treating c3 glomerulopathy | |
| SG11201908971RA (en) | Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene | |
| SG11201907867TA (en) | Use of anti-ctla-4 antibodies with enhanced adcc to enhance immune response to a vaccine | |
| SG11201807809XA (en) | A transient commensal microorganism for improving gut health | |
| SG11201810757YA (en) | Non-human animals expressing exogenous terminal deoxynucleotidyltransferase | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201807574XA (en) | Beta-caseins and cognitive function | |
| SG11201809751XA (en) | Egfr inhibitor compounds | |
| SG11201902531QA (en) | Liquid pharmaceutical composition | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201809527UA (en) | Methods of treating circadian rhythm sleep disorders | |
| SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201804821PA (en) | A beverage capsule | |
| SG11201909003YA (en) | Integrated vascular access device and anchor pad | |
| SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201903193WA (en) | Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate | |
| SG11201908513RA (en) | Peptides for treatment of diabetes | |
| SG11201807516UA (en) | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar | |
| SG11201810940XA (en) | Methods of treating pancreatic cancer | |
| SG11201807283XA (en) | Rider-controlled trackless ride system |